Compared to a population of healthy children, high-risk ALL patients with the C282Y and/or H63D allelic variants in the HFE gene had significantly lower LV function, mass, and wall thickness two years after their diagnosis [35]. This evidence concerns the gene HFE and acute lymphoblastic leukemia.